Literature DB >> 22391152

Immunodominance: a pivotal principle in host response to viral infections.

Ali Akram1, Robert D Inman.   

Abstract

We encounter pathogens on a daily basis and our immune system has evolved to mount an immune response following an infection. An interesting phenomenon that has evolved in response to clearing bacterial and viral infections is called immunodominance. Immunodominance refers to the phenomenon that, despite co-expression of multiple major histocompatibility complex class I alleles by host cells and the potential generation of hundreds of distinct antigenic peptides for recognition following an infection, a large portion of the anti-viral cytotoxic T lymphocyte population targets only some peptide/MHC class I complexes. Here we review the main factors contributing to immunodominance in relation to influenza A and HIV infection. Of special interest are the factors contributing to immunodominance in humans and rodents following influenza A infection. By critically reviewing these findings, we hope to improve understanding of the challenges facing the discovery of new factors enabling better anti-viral vaccine strategies in the future.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22391152     DOI: 10.1016/j.clim.2012.01.015

Source DB:  PubMed          Journal:  Clin Immunol        ISSN: 1521-6616            Impact factor:   3.969


  49 in total

Review 1.  [Combination of Oncolytic Virotherapy and CAR T/NK Cell Therapy for the Treatment of Cancer].

Authors:  G V Kochneva; G F Sivolobova; A V Tkacheva; A A Gorchakov; S V Kulemzin
Journal:  Mol Biol (Mosk)       Date:  2020 Jan-Feb

2.  The viral transcription group determines the HLA class I cellular immune response against human respiratory syncytial virus.

Authors:  Carolina Johnstone; Elena Lorente; Alejandro Barriga; Eilon Barnea; Susana Infantes; François A Lemonnier; Chella S David; Arie Admon; Daniel López
Journal:  Mol Cell Proteomics       Date:  2015-01-29       Impact factor: 5.911

3.  Bayesian multiple instance regression for modeling immunogenic neoantigens.

Authors:  Seongoh Park; Xinlei Wang; Johan Lim; Guanghua Xiao; Tianshi Lu; Tao Wang
Journal:  Stat Methods Med Res       Date:  2020-05-13       Impact factor: 3.021

Review 4.  Pathways of antigen processing.

Authors:  Janice S Blum; Pamela A Wearsch; Peter Cresswell
Journal:  Annu Rev Immunol       Date:  2013-01-03       Impact factor: 28.527

Review 5.  The prospects and challenges of universal vaccines for influenza.

Authors:  Kanta Subbarao; Yumiko Matsuoka
Journal:  Trends Microbiol       Date:  2013-05-17       Impact factor: 17.079

6.  Graph-theoretical formulation of the generalized epitope-based vaccine design problem.

Authors:  Emilio Dorigatti; Benjamin Schubert
Journal:  PLoS Comput Biol       Date:  2020-10-23       Impact factor: 4.475

7.  Immunodominant West Nile Virus T Cell Epitopes Are Fewer in Number and Fashionably Late.

Authors:  Saghar Kaabinejadian; Curtis P McMurtrey; Sojung Kim; Rinki Jain; Wilfried Bardet; Fredda B Schafer; Jason L Davenport; Aaron D Martin; Michael S Diamond; Jon A Weidanz; Ted H Hansen; William H Hildebrand
Journal:  J Immunol       Date:  2016-04-20       Impact factor: 5.422

8.  SEPPA 2.0--more refined server to predict spatial epitope considering species of immune host and subcellular localization of protein antigen.

Authors:  Tao Qi; Tianyi Qiu; Qingchen Zhang; Kailin Tang; Yangyang Fan; Jingxuan Qiu; Dingfeng Wu; Wei Zhang; Yanan Chen; Jun Gao; Ruixin Zhu; Zhiwei Cao
Journal:  Nucleic Acids Res       Date:  2014-05-16       Impact factor: 16.971

9.  Integrative proteomics identifies thousands of distinct, multi-epitope, and high-affinity nanobodies.

Authors:  Yufei Xiang; Zhe Sang; Lirane Bitton; Jianquan Xu; Yang Liu; Dina Schneidman-Duhovny; Yi Shi
Journal:  Cell Syst       Date:  2021-02-15       Impact factor: 10.304

Review 10.  The Dynamic Entropy of Tumor Immune Infiltrates: The Impact of Recirculation, Antigen-Specific Interactions, and Retention on T Cells in Tumors.

Authors:  Tiffany C Blair; Alejandro F Alice; Lauren Zebertavage; Marka R Crittenden; Michael J Gough
Journal:  Front Oncol       Date:  2021-04-22       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.